PI
ELGX

Putnam Investments’s Endologix Inc ELGX Stock Holding History

Putnam Investments’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,366
Closed -$431K – 1321
2016
Q3 		$431K Buy
+3,366
New +$431K ﹤0.01% 1146

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Putnam Investments's ELGX Position: Q4 2016 in Review

Putnam Investments sold out of Endologix Inc (ELGX) in Q4 2016, closing a stake of 3,366 shares — an estimated $431K sold.

Putnam Investments first reported a position in ELGX in Q3 2016 and held it in 1 quarter. The position peaked at $431K in Q3 2016. 140 funds tracked by Wall St. Rank hold ELGX as of Q4 2016.

  • Putnam Investments reported no remaining Endologix Inc position as of Q4 2016 after selling out during the quarter.
  • Putnam Investments sold 3,366 Endologix Inc shares in Q4 2016, an estimated $431K.
  • Putnam Investments first reported a position in Endologix Inc in Q3 2016 and held it in 1 quarter.
  • Putnam Investments's Endologix Inc position peaked at $431K in Q3 2016.
  • 140 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2016.

Based on Putnam Investments's 13F filing for Q4 2016, filed 14 Feb 2017.